Institutional investors purchased a net $9.6 million shares of EXAS during the quarter ended December 2014 and now own 95.70% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
J&P (CHINA) CAPITAL MANAGEMENT C... Bought 3.1 Million shares of Exact Sciences Corp
FIDELITY MANAGEMENT & RESEARCH C... Bought 2.9 Million shares of Exact Sciences Corp
POINT72 ASSET MANAGEMENT LP Bought 2.0 Million shares of Exact Sciences Corp